MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Motor control"

  • MDS Virtual Congress 2020

    Rhythmic movements decompose in Parkinson’s disease with worse disease severity at low frequencies: akinesia or impaired ability to move more slowly than comfortable?

    S. Israeli-Korn, A. Korakin, N. Vaadia, S. Hassin-Baer, J. Friedman (Tel Hashomer, Israel)

    Objective: To explore the relationship between disease severity, minimum comfortable velocity and dwell time in Parkinson's disease. Background: People find it hard to move smoothly…
  • MDS Virtual Congress 2020

    Motor onset of Parkinsonʼs disease: Is there a somatotopic pattern?

    M. Monje, A. Sánchez-Ferro, L. Vela-Desojo, F. Alonso-Frech, M. Di Leone, J. Pineda-Pardo, G. Foffani, J. Obeso (Móstoles, Madrid, Spain)

    Objective: To study the clinical onset and progression of motor manifestations in different body regions in early PD patients. Background: The vulnerability of the nigrostriatal…
  • MDS Virtual Congress 2020

    Real Time Quality Control for Subjective Endpoints in Clinical Trials

    Y. Peng, G. Morinan, J. O'Keeffe (London, United Kingdom)

    Objective: Here we present a system which is capable of performing nearly-real time monitoring of UPDRS part-3 motor assessments using a combination of multidimensional statistics…
  • MDS Virtual Congress 2020

    A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AKST4290 in Subjects with Parkinson’s Disease on Stable Dopaminergic Treatment (TEAL Study)

    E. Rawner, J. Powell, S. Minami, K. Tang, V. Klutzaritz, E. McCaskill Newman, J. Hannestad (San Carlos, CA, USA)

    Objective: Assessment of efficacy and safety in subjects with Parkinson’s disease (PD) following treatment for 12 weeks with placebo or AKST4290, a highly specific and…
  • 2019 International Congress

    What connectivity tells us about neurodegeneration in Huntington disease? A fMRI study

    P. de Azevedo, M. Nogueira, L. Ribeiro, B. de Campos, R. Guimarães, L. Piovesana, F. Cendes, I. Lopes-Cendes, C. Yasuda (Campinas, Brazil)

    Objective: Our study investigated the impact of Huntington disease (HD) on brain connectivity, through resting-state (RS) fMRI, among the most critical regions associated with physiopathology.…
  • 2019 International Congress

    A general impaired-rhythm system underpins oro-motor, manual, and gait rhythmic disturbances in Parkinson’s disease

    F. Puyjarinet, V. Bégel, C. Gény, V. de Cock, V. Driss, M. Cuartero, S. Pinto, S. Dalla Bella (Montpellier, France)

    Objective: To assess whether rhythmic disturbances in three different domains (i.e., oro-motor, finger tapping and gait domains) are related in Parkinson's disease (PD), and to…
  • 2019 International Congress

    Gender differences for Motor and non motor symptoms in Parkinson’s Disease among Pakistani population

    S. Naureen, A. Arshad, N. Ahmad (Islamabad, Pakistan)

    Objective: Parkinson’s disease is second most common neurodegenerative t disorder with increasing burden  in under developed countries with poor health facilities. Motor and non motor…
  • 2019 International Congress

    The Effect of Gocovri on Motor Aspects of Experiences of Daily Living: Analyses of MDS-UPDRS Part II Data from a Phase 3 Program

    R. Hauser, D. Kremens, D. Chernick, R. Patni, J. Hubble (Tampa, FL, USA)

    Objective: To assess the impact of Gocovri® (amantadine) extended release capsules on motor aspects of experiences of daily living in PD patients. Background: Gocovri is…
  • 2019 International Congress

    Evaluation of Constipation in Patients with Parkinson’s Disease and its Correction

    M. Salokhiddinov, D. Akramova (Tashkent, Uzbekistan)

    Objective: To evaluate the possible causes of constipation, and to find clear methods to correct the disorder. Background: Constipation is a common problem in Parkinson's…
  • 2019 International Congress

    One-year follow-up of subthalamic deep brain stimulation in Parkinson’s disease

    L. Barcelos, M. Tosin, M. Marinho, C. Silva, R. Saba, S. Silva, V. Borges, H. Ferraz (Sao Paulo, Brazil)

    Objective: To report the results of one-year follow-up of subthalamic deep brain stimulation in Parkinson's disease on 19 patients bilaterally implanted at Federal University of…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 40
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley